胺碘酮治疗心力衰竭合并快速型心律失常患者80例临床分析

Clinical Analysis of Amiodarone in the Treatment of 80 Cases of Heart Failure Complicated with Tachyarrhythmias

目的观察胺碘酮治疗心力衰竭合并快速型心律失常患者的临床疗效及安全性。方法选取我院收治的80例心力衰竭合并快速型心律失常患者作为研究对象,采用数字随机表法将其随机分为观察组(40例)和对照组(40例),对照组患采用常规治疗方案治疗,观察组患者在常规治疗基础上再予以胺碘酮治疗,比较两组患者治疗后心功能分级变化情况及心率改变情况。结果两组患者治疗后,心功能及心率均获改善(P<0.05),但观察组患者改善效果明显优于对照组(P<0.05),两组患者治疗过程中均无明显不良反应。结论胺碘酮辅助治疗心力衰竭合并快速型心律失常患者疗效确切,未增加不良反应。

Objective To observe the clinical effect and safety of amiodarone in the treatment of heart failure complicated with tachyarrhythmias. Methods80 cases of patients with heart failure and tachyarrhythmia in our hospital were selected as research subjects and randomly divided into observation group（40 cases） and control group（40 cases）. Control group used conventional treatment while observation group added amiodarone treatment based on conventional treatment. Results After treatment, cardiac function and heart rate in both groups improved（P〈0.05）, but observation group improved better than the control group（P〈0.05）; during treatment patients in two groups had no obvious adverse reactions. Conclusion Amiodarone adjuvant therapy in patients with heart failure and tachyarrhythmias has significant efficacy, without increasing adverse reactions.